Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001653477-25-000085
Filing Date
2025-05-05
Accepted
2025-05-05 18:38:06
Documents
6
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1746484678.html 4  
1 FORM 4 wk-form4_1746484678.xml 4 3268
2 EX-24.1 ngvt_poax-xedgarxnextfer.htm EX-24.1 9465
3 ngvt_poax-xedgarxnextfer001.jpg GRAPHIC 251263
4 ngvt_poax-xedgarxnextfer002.jpg GRAPHIC 227003
5 ngvt_poax-xedgarxnextfer003.jpg GRAPHIC 46009
6 ngvt_poax-xedgarxnextfer004.jpg GRAPHIC 61340
  Complete submission text file 0001653477-25-000085.txt   821188
Mailing Address ASHLAND INC. 8145 BLAZER DRIVE WILMINGTON DE 19808
Business Address
FERNANDEZ-MORENO LUIS M (Reporting) CIK: 0001434786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37586 | Film No.: 25914572

Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Issuer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)